Xiaofang Xing
- Topics
- Cancer Immunotherapy and Biomarkers (5 papers)Gastric Cancer Management and Outcomes (4 papers)Cancer-related molecular mechanisms research (3 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Xiaofang Xing
14 papers receiving 384 citations
Peers
Comparison fields: 5 of 40
- Oncology 191
- Molecular Biology 188
- Cancer Research 140
- Pulmonary and Respiratory Medicine 102
- Immunology 101
Countries citing papers authored by Xiaofang Xing
This map shows the geographic impact of Xiaofang Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofang Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofang Xing more than expected).
Fields of papers citing papers by Xiaofang Xing
This network shows the impact of papers produced by Xiaofang Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofang Xing. The network helps show where Xiaofang Xing may publish in the future.
Co-authorship network of co-authors of Xiaofang Xing
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofang Xing. A scholar is included among the top collaborators of Xiaofang Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofang Xing. Xiaofang Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 1 | |
| 4 | 40 | |
| 5 | 16 | |
| 6 | 18 | |
| 7 | 117 | |
| 8 | 5 | |
| 9 | 23 | |
| 10 | 11 | |
| 11 | 1 | |
| 12 | 22 | |
| 13 | 103 | |
| 14 | 23 | |
| 15 | 16. Phospholipase A2 group IIA expression correlates with prolonged survival in gastric cancer | 1 |
About Xiaofang Xing
Xiaofang Xing is a scholar working on Cancer Research, Oncology and Immunology, having authored 15 papers that have together received 386 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (140 citations), Oncology (191 citations) and Immunology (101 citations). Xiaofang Xing has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Jiafu Ji, Ziyu Li, Xiangyu Gao, Ting Guo, Xiaolong Wu, Xiaohuan Tang, Hong Du, Xiaojing Cheng, Zhaode Bu and Lianhai Zhang. Their work appears in journals such as Journal of Clinical Oncology, Molecular Cancer and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.